Hemogenyx Pharmaceuticals Plc Current Assets

Hemogenyx Pharmaceuticals Plc (HEMO.L) currently reports a current assets of $4.9M as of June 2026. That compares with $570K in the prior-year period — up 753.3% year over year. Use the charts on this page to explore Hemogenyx Pharmaceuticals Plc's current assets history and peer comparisons.

Hemogenyx Pharmaceuticals Plc's current assets increased from $570K to $4.9M — a 753.3% year-over-year increase (period ending June 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Hemogenyx Pharmaceuticals Plc reported $4.9M in current assets as of June 2026. That compares with $570K in the prior-year period — up 753.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current current assets of $4.9M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Hemogenyx Pharmaceuticals Plc, and consider following HEMO.L for alerts when major investors trade the stock.

Hemogenyx Pharmaceuticals Plc is classified in the Healthcare sector. On current assets, it currently shows $4.9M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HEMO.L with unrelated industries.